TRCT
INAB icon

Tower Research Capital (TRC)’s IN8bio INAB Stock Holding History

Tower Research Capital (TRC)’s Portfolio INAB Stock Details INAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.87K Sell
1,265
-1,185
-48% -$2.29K ﹤0.01% 4591
2025
Q4 		$5.73K Sell
2,450
-605
-20% -$1.15K ﹤0.01% 4100
2025
Q3 		$6.63K Buy
3,055
+1,538
+101% +$3.38K ﹤0.01% 4149
2025
Q2 		$3.17K Buy
1,517
+841
+124% +$3.42K ﹤0.01% 4539
2025
Q1 		$3.37K Buy
676
+57
+9% +$455 ﹤0.01% 4426
2024
Q4 		$4.77K Buy
619
+179
+41% +$1.57K ﹤0.01% 4399
2024
Q3 		$3.56K Buy
440
+314
+249% +$5.69K ﹤0.01% 4823
2024
Q2 		$3.21K Sell
126
-237
-65% -$7.61K ﹤0.01% 4922
2024
Q1 		$12.9K Buy
363
+160
+79% +$6.04K ﹤0.01% 3440
2023
Q4 		$8.4K Sell
203
-188
-48% -$6.01K ﹤0.01% 4514
2023
Q3 		$12.2K Buy
391
+165
+73% +$6.19K ﹤0.01% 3918
2023
Q2 		$10.4K Buy
226
+63
+39% +$3.94K ﹤0.01% 4121
2023
Q1 		$6K Sell
163
-59
-27% -$3.29K ﹤0.01% 4846
2022
Q4 		$15K Buy
222
+161
+264% +$9.01K ﹤0.01% 3420
2022
Q3 		$4K Sell
61
-12
-16% -$806 ﹤0.01% 5259
2022
Q2 		$5K Sell
73
-40
-35% -$3.38K ﹤0.01% 5057
2022
Q1 		$11K Buy
113
+7
+7% +$783 ﹤0.01% 4179
2021
Q4 		$14K Buy
106
+9
+9% +$1.78K ﹤0.01% 4077
2021
Q3 		$20K Buy
+97
New +$24.1K ﹤0.01% 3711

Other funds holding INAB

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
OC
Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return

Tower Research Capital (TRC)'s INAB Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its IN8bio (INAB) stake by 48% in Q1 2026, selling an estimated $2.29K and leaving 1,265 shares worth $1.87K. The position accounts for ﹤0.01% of the portfolio, ranked #4591.

Tower Research Capital (TRC) first reported a position in INAB in Q3 2021 and has held it in 19 quarters since. The position peaked at $20K in Q3 2021. 19 funds tracked by Wall St. Rank hold INAB as of Q1 2026.

  • Tower Research Capital (TRC) held 1,265 shares of IN8bio worth $1.87K as of Q1 2026.
  • Tower Research Capital (TRC) sold 1,185 IN8bio shares in Q1 2026, an estimated $2.29K.
  • IN8bio made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #4591 holding.
  • Tower Research Capital (TRC) first reported a position in IN8bio in Q3 2021 and has held it in 19 quarters since.
  • Tower Research Capital (TRC)'s IN8bio position peaked at $20K in Q3 2021.
  • 19 funds tracked by Wall St. Rank held IN8bio as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.